Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro
PaperCitations, authors & open-access status
Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 206 citations, 2014 year and closed oa status.
206
Citations
2014
Year
closed
OA Status